Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria

被引:6
|
作者
Scotney, Soleine [1 ]
Snidal, Sarah [2 ]
Saidu, Yauba [3 ]
Ojumu, Abiola [4 ]
Ngatia, Antony [1 ]
Bagana, Murtala [4 ]
Mutuku, Faith [1 ]
Sobngwi, Joelle [3 ]
Efe-Aluta, Oniovo [4 ]
Roper, Julia [4 ]
LeTallec, Yann [5 ]
Kang'ethe, Alice [1 ]
机构
[1] Clinton Hlth Access Initiat, Vaccines Delivery Team, Nairobi, Kenya
[2] Clinton Hlth Access Initiat, Vaccines Delivery Team, Kampala, Uganda
[3] Clinton Hlth Access Initiat, Vaccines Delivery Team, Yaounde, Cameroon
[4] Clinton Hlth Access Initiat, Vaccines Delivery Team, Abuja, Nigeria
[5] Clinton Hlth Access Initiat, Vaccines Delivery Team, Zurich, Switzerland
来源
关键词
Polio; IPV; NVI; technical working groups; RI; program management;
D O I
10.1093/infdis/jiw544
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introducing a new vaccine is a large-scale endeavor that can face many challenges, resulting in introduction delays and inefficiencies. The development of national task teams and tools, such as prelaunch trackers, for the introduction of new vaccines (hereafter, "new vaccine introductions" [NVIs]) can help countries implement robust project management systems, front-load critical preparatory activities, and ensure continuous communication around vaccine supply and financing. In addition, implementing postlaunch assessments to take rapid corrective action accelerates the uptake of the new vaccines. NVIs can provide an opportunity to strengthen routine immunization, through strengthening program management systems or by reinforcing local immunization managers' abilities, among others. This article highlights key lessons learned during the introduction of inactivated poliovirus vaccine in 3 countries that would make future NVIs more successful. The article concludes by considering how the Immunization Systems Management Group of the Global Polio Eradication Initiative has been useful to the NVI process and how such global structures could be further enhanced.
引用
收藏
页码:S130 / S136
页数:7
相关论文
共 50 条
  • [1] Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Bangladesh
    Estivariz, Concepcion F.
    Snider, Cynthia J.
    Anand, Abhijeet
    Hampton, Lee M.
    Bari, Tajul I.
    Billah, Mallick M.
    Chai, Shua J.
    Wassilak, Steven G.
    Heffelfinger, James D.
    Zaman, K.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S122 - S129
  • [2] Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016
    Hampton, Lee M.
    Farrell, Margaret
    Ramirez-Gonzalez, Alejandro
    Menning, Lisa
    Shendale, Stephanie
    Lewis, Ian
    Rubin, Jennifer
    Garon, Julie
    Harris, Jennifer
    Hyde, Terri
    Wassilak, Steven
    Patel, Manish
    Nandy, Robin
    Chang-Blanc, Diana
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (35): : 934 - 938
  • [3] CONSEQUENCES OF THE INTRODUCTION OF THE NEW INACTIVATED POLIOVIRUS VACCINE INTO THE EXPANDED PROGRAM ON IMMUNIZATION
    MARTIN, JF
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1984, 6 : S480 - S482
  • [4] Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016
    Hampton, Lee M.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (25): : 699 - 702
  • [5] Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame
    Zipursky, Simona
    Patel, Manish
    Farrell, Margaret
    Gonzalez, Alejandro Ramirez
    Kachra, Tasleem
    Folly, Yann
    Kurji, Feyrouz
    Veira, Chantal Laroche
    Wootton, Emily
    Hampton, Lee M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S15 - S23
  • [6] Change from oral poliovirus vaccine to inactivated poliovirus vaccine
    Mele, A
    Jefferson, T
    Franco, E
    Salmaso, S
    [J]. LANCET, 2002, 360 (9340): : 1178 - 1178
  • [7] Supporting new vaccine introduction decisions: Lessons learned from the Hib Initiative experience
    Hajjeh, R. A.
    Privor-Dumm, L.
    Edmond, K.
    O'Loughlin, R.
    Shetty, S.
    Griffiths, U. K.
    Bear, A. P.
    Cohen, A. L.
    Chandran, A.
    Schuchat, A.
    Mulholland, E. K.
    Santosham, M.
    [J]. VACCINE, 2010, 28 (43) : 7123 - 7129
  • [8] Rotavirus vaccine introduction in the Americas: progress and lessons learned
    de Oliveira, Lucia Helena
    Danovaro-Holliday, M. Carolina
    Matus, Cuauhtemoc Ruiz
    Andrus, Jon Kim
    [J]. EXPERT REVIEW OF VACCINES, 2008, 7 (03) : 345 - 353
  • [9] Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
    Tevi-Benissan, Carol
    Okeibunor, Joseph
    du Chatellier, Gael Maufras
    Assefa, Afework
    Biey, Joseph Nsiari-Muzenyi
    Cheikh, Dah
    Eshetu, Messeret
    Anya, Blanche-Philomene
    Dao, Halima
    Nasir, Yusuf
    Akanmori, Bartholomew Dicky
    Mihigo, Richard
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S66 - S75
  • [10] Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
    Jamka, Leslie P.
    Simiyu, Kenneth W.
    Bentsi-Enchill, Adwoa D.
    Mwisongo, Aziza J.
    Matzger, Helen
    Marfin, Anthony A.
    Pollard, Andrew J.
    Neuzil, Kathleen M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 : S171 - S176